MannKind Corporation

(MNKD) Trade

By |

Profile

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Contact Information

Website: www.mannkindcorp.com
Main Phone: +1 818 661-5000
Address: 30930 Russell Ranch Road
Address 2: Suite 300
State: CA
City / Town: Westlake Village
Country: USA
Postal Code: 91362

Issuer Information

Exchange: NSD
CEO: Michael E. Castagna
Employees: 233
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Contact Information

Website: www.mannkindcorp.com
Main Phone: +1 818 661-5000
Address: 30930 Russell Ranch Road
Address 2: Suite 300
State: CA
City / Town: Westlake Village
Country: USA
Postal Code: 91362

Issuer Information

Exchange: NSD
CEO: Michael E. Castagna
Employees: 233
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 1.03 $ -0.05 (-4.63%)
Last Price 1.03 Change $ -0.05 Change % -4.63 Tick N/A
Bid 1.01 Bid Size 24,600.00 Ask 1.02 Ask Size 800.00
Open 1.08 High 1.08 Low 1.01 Prev Close 1.08
Last Trade Volume 2.4 mi 52 Wk Hi 1.92 52 Wk Low 0.81
Market Cap 218.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 212,295,318.00 EPS (TTM) -0.27 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 20
Number of Buys 0 6
Number of Sells 0 14
Net Activity 0 214488
Last 10 Buys Shares
Stuart A. Tross 1,000
Michael E. Castagna 1,000
Michael E. Castagna 1,000
Kent Kresa 1,000
Rosabel R. Alinaya 1,000
Matthew J. Pfeffer 1,000
Matthew J. Pfeffer 1,000
Rosabel R. Alinaya 1,000
Michael E. Castagna 1,000
Michael E. Castagna 1,000
Last 10 Sell Shares
Raymond Urbanski 1,000
Rosabel R. Alinaya 1,000
Hakan S. Edstrom 1,000
Hakan S. Edstrom 1,000
Juergen A. Martens 1,000
David Thomson 1,000
Hakan S. Edstrom 1,000
David Thomson 1,000
Diane M. Palumbo 1,000
Diane M. Palumbo 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 1 1 1 1
Mean Target Price Estimate 3 3 3 3
Standard Deviation 2.83 2.83 2.83 2.83
Date of Most Recent Estimate 05/10/18 05/10/18 05/10/18 05/10/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 3 3 3 3